PDK1 and neoplasm: In some pathophysiological conditions, including tumor progression, SIRT1 seemed to activate protective signaling pathways controlled by AKT (serine/threonine-specific protein kinases) and PDK1 (phosphoinositide-dependent protein kinase 1) [19].